Randomized Controlled Trial of Aerobic Exercise on Insulin and Insulin-like Growth Factors in Breast Cancer Survivors: The Yale Exercise and Survivorship Study
Background: High insulin and insulin-like growth factor-I (IGF-I) levels may be associated with an increased breast cancer risk and/or death. Given the need to identify modifiable factors that decrease insulin, IGF-I, and breast cancer risk and death, we investigated the effects of a 6-month randomi...
Saved in:
Published in | Cancer epidemiology, biomarkers & prevention Vol. 18; no. 1; pp. 306 - 313 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Association for Cancer Research
01.01.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: High insulin and insulin-like growth factor-I (IGF-I) levels may be associated with an increased breast cancer
risk and/or death. Given the need to identify modifiable factors that decrease insulin, IGF-I, and breast cancer risk and
death, we investigated the effects of a 6-month randomized controlled aerobic exercise intervention versus usual care on fasting
insulin, IGF-I, and its binding protein (IGFBP-3) in postmenopausal breast cancer survivors.
Methods: Seventy-five postmenopausal breast cancer survivors were identified from the Yale-New Haven Hospital Tumor Registry
and randomly assigned to an exercise ( n = 37) or usual care ( n = 38) group. The exercise group participated in 150 minutes per week of moderate-intensity aerobic exercise. The usual care
group was instructed to maintain their current physical activity level. A fasting blood sample was collected on each study
participant at baseline and 6 months. Blood levels of insulin and IGF were measured with ELISA.
Results: On average, exercisers increased aerobic exercise by 129 minutes per week compared with 45 minutes per week among
usual care participants ( P < 0.001). Women randomized to exercise experienced decreases in insulin, IGF-I, and IGFBP-3, whereas women randomized to
usual care had increases in these hormones. Between-group differences in insulin, IGF-I, and IGFBP-3 were 20.7% ( P = 0.089), 8.9% ( P = 0.026), and 7.9% ( P = 0.006), respectively.
Conclusions: Moderate-intensity aerobic exercise, such as brisk walking, decreases IGF-I and IGFBP-3. The exercise-induced
decreases in IGF may mediate the observed association between higher levels of physical activity and improved survival in
women diagnosed with breast cancer. (Cancer Epidemiol Biomarkers Prev 2009;18(1):306–13) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1055-9965 1538-7755 |
DOI: | 10.1158/1055-9965.EPI-08-0531 |